| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q | ||
8-K | CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights | ||
SCHEDULE 13G/A | FMR LLC (Filed by) | ||
8-K | CAMP4 Therapeutics Provides Clinical and Pipeline Updates at September 2026 Analyst Day | ||
4 | Gold Kelly (Reporting) | ||
SCHEDULE 13D/A | 5AM Ventures VI, L.P. (Filed by) | ||
4 | Schwab Andrew J. (Reporting) | ||
4 | Schwab Andrew J. (Reporting) | ||
4 | Schwab Andrew J. (Reporting) | ||
4 | Tardiff Daniel (Reporting) | ||
SCHEDULE 13D/A | Polaris Management Co. VII, L.L.C. (Filed by) | ||
144 | Form 144 |
